Who Paid My Doc
Ryan Stringer
Hospice and Palliative Medicine Grand Rapids, MI Doctor of Osteopathy
NPI 1962847756 CMS profile 448052
200 Jefferson Ave Se, Grand Rapids, MI 49503
General payments
$4,438
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Ryan Stringer of Grand Rapids, MI is reported in the CMS Open Payments database as having received $4,438 across 52 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
By program year
3 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $2,374 | 32 | |
| 2024 | General | $2,049 | 19 | |
| 2022 | General | $15 | 1 |
Beside peers
- Ryan Stringer
- Hospice and Palliative Medicine median
- Middle half of Hospice and Palliative Medicine
- National median
In program year 2024, general payments to Ryan Stringer were reported at $2,049. Among 22 Hospice and Palliative Medicine profiles paid that year, the median was $119 and the middle half received between $44 and $165.
Show as a table
| Year | Ryan Stringer | Hospice and Palliative Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $49 | $16–$122 | $163 |
| 2020 | $0 | — | — | $114 |
| 2021 | $0 | — | — | $132 |
| 2022 | $15 | $30 | $18–$119 | $149 |
| 2023 | $0 | — | — | $160 |
| 2024 | $2,049 | $119 | $44–$165 | $164 |
| 2025 | $2,374 | — | — | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 17 billing codesPaid by Medicare
$11,998
Medicare patients
75
Services billed
152
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 51% | |
| Chronic kidney disease | 45% | |
| Depression | 45% | |
| Heart failure | 43% | |
| Diabetes | 41% | |
| Ischemic heart disease | 37% | |
| Atrial fibrillation | 32% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
52 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Hospice and Palliative Medicine in Michigan
Paven Uppal
Hospice and Palliative Medicine · Ypsilanti, MI
Bradley Heth
Hospice and Palliative Medicine · Mount Clemens, MI
Eric Herrera
Hospice and Palliative Medicine · Royal Oak, MI
Patrick Hawley
Hospice and Palliative Medicine · Detroit, MI
H Maas
Hospice and Palliative Medicine · Clinton Township, MI
Robert Zalenski
Hospice and Palliative Medicine · Rochester Hills, MI
Related records
Hospice and Palliative Medicine in Michigan
Practitioners in the same specialty and state, ranked by reported value.
All Hospice and Palliative Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Michigan
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.